Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Dimopoulos, Meletios A, Gay, Francesca, Schjesvold, Fredrik, Beksac, Meral, Hajek, Roman, Weisel, Katja Christina, Goldschmidt, Hartmut, Maisnar, Vladimir, Moreau, Philippe, Min, Chang Ki, Pluta, AgniLanguage:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(18)33003-4
Date:
December, 2018
File:
PDF, 824 KB
english, 2018